• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Distoken Acquisition Corporation

    5/30/25 4:07:11 PM ET
    $DIST
    Blank Checks
    Finance
    Get the next $DIST alert in real time by email
    DEFA14A 1 formadef14a.htm DEFA14A

     

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

     

     

    SCHEDULE 14A

     

     

     

    Proxy Statement Pursuant to Section 14(a) of the
    Securities Exchange Act of 1934

     

    Filed by the Registrant   ☒
    Filed by a Party other than the Registrant   ☐

     

    Check the appropriate box:

     

    ☐   Preliminary Proxy Statement
    ☐   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
    ☐   Definitive Proxy Statement
    ☒   Definitive Additional Materials
    ☐   Soliciting Material Pursuant to Section 240.14a-12

     

    Distoken Acquisition Corporation

    (Name of Registrant as Specified In Its Charter)

     

     

     

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

     

    Payment of Filing Fee (Check the appropriate box):

     

    ☒   No fee required.
    ☐   Fee paid previously with preliminary materials.
    ☐   Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

     

     

     

     

     

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

     

    Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): May 30, 2025

     

    Distoken Acquisition Corporation

    (Exact name of registrant as specified in its charter)

     

    Cayman Islands   001-41622   N/A

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

      (I.R.S. Employer
    Identification No.)

     

    Unit 1006, Block C, Jinshangjun Park
    No. 2 Xiaoba Road, Panlong District
    Kunming, Yunnan, China
      N/A
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: +86 871 63624579

     

    Not Applicable

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Ordinary shares, par value $0.0001 per share   DIST   The Nasdaq Stock Market LLC
    Redeemable warrants, each warrant entitling the holder to purchase one ordinary share at a price of $11.50 per share   DISTW   The Nasdaq Stock Market LLC
    Rights, each right entitling the holder to receive one-tenth of one ordinary share   DISTR   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     
     

     

    Item 1.01. Entry Into a Material Definitive Agreement.

     

    As previously announced, on May 17, 2024, Distoken Acquisition Corporation, a Cayman Islands exempted company (“Distoken” or the “Company”), entered into a definitive business combination agreement, as amended on November 13, 2024 and January 17, 2025 (as it may be further amended, supplemented and/or restated from time to time, the “Business Combination Agreement”) with Youlife Group Inc., a Cayman Islands exempted company (“Pubco”), Xiaosen Sponsor LLC, a Cayman Islands limited liability company (the “Sponsor”), Youlife I Limited, a Cayman Islands exempted company and a wholly-owned subsidiary of Pubco (“First Merger Sub”), Youlife II Limited, a Cayman Islands exempted company and a wholly-owned subsidiary of Pubco (“Second Merger Sub”), and Youlife International Holdings Inc., a Cayman Islands exempted company (“Youlife”), for a proposed business combination among the parties (the “Business Combination”). Pursuant to the Business Combination Agreement, Pubco will serve as the parent company of each of Distoken and Youlife following the consummation of the Business Combination.

     

    As previously disclosed in Current Reports on Form 8-K filed by Distoken on April 16, 2025 and April 28, 2025, on such dates, Distoken and Pubco entered into subscription agreements (the “Subscription Agreements”) with certain investors (the “Subscribers”) to purchase an aggregate of 2,704,949 Class A ordinary shares, par value $0.0001 per share, of Pubco ( “Shares”), at a price of $10.00 per Share, for an aggregate purchase price of $27,049,490, in a private placement to be consummated simultaneously with the closing of the Business Combination.

     

    On May 30, 2025, Distoken and Pubco entered into an amendment to the Subscription Agreements (the “Amendment”) with the investors to remove the May 31, 2025 termination date and to provide that any party may terminate the agreement if the Business Combination is not completed by June 30, 2025.

     

    The foregoing description of the Amendment does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the form of the Amendment, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and which is incorporated herein by reference.

     

    Additional Information About the Business Combination and Where to Find It

     

    This Current Report on Form 8-K relates to a proposed Business Combination between Distoken and Youlife. In connection with the Business Combination, Pubco has filed with the Securities and Exchange Commission (the “SEC”) a registration statement on Form F-4, as amended (the “Registration Statement”), which includes a definitive proxy statement of Distoken and a definitive prospectus of Pubco, which Registration Statement was declared effective by the SEC on March 31, 2025 and May 14, 2025. The definitive proxy statement, filed with the SEC by Distoken on April 2, 2025, and related materials for the Business Combination were mailed to the shareholders of Distoken as of a record date of March 27, 2025 on April 4, 2025 and May 16, 2025. This communication does not contain all the information that should be considered concerning the Business Combination and is not intended to form the basis of any investment decision or any other decision in respect of the Business Combination. DISTOKEN’S AND YOULIFE’S SHAREHOLDERS AND OTHER INTERESTED PERSONS ARE ADVISED TO READ THE DEFINITIVE PROXY STATEMENT/PROSPECTUS AND OTHER DOCUMENTS FILED IN CONNECTION WITH THE BUSINESS COMBINATION, AS THESE MATERIALS CONTAIN IMPORTANT INFORMATION ABOUT DISTOKEN, YOULIFE, PUBCO AND THE BUSINESS COMBINATION. Shareholders and other interested persons will also be able to obtain copies of the definitive proxy statement/prospectus and other documents filed with the SEC, without charge, once available, at the SEC’s website at www.sec.gov, or by directing a request to: Distoken Acquisition Corporation, Unit 1006, Block C, Jinshangjun Park, No. 2 Xiaoba Road, Panlong District, Kunming, Yunnan, China; Tel: +86 871 63624579.

     

     
     

     

    Participants in the Solicitation

     

    Distoken and its directors and executive officers may be deemed participants in the solicitation of proxies from Distoken’s shareholders with respect to the Business Combination. A list of the names of those directors and executive officers of Distoken is contained in Distoken’s Annual Report on Form 10-K filed with the SEC on March 7, 2025, which is available free of charge at the SEC’s web site at www.sec.gov, or by directing a request to: Distoken Acquisition Corporation, Unit 1006, Block C, Jinshangjun Park, No. 2 Xiaoba Road, Panlong District, Kunming, Yunnan, China; Tel: +86 871 63624579. Additional information regarding the interests of such participants will be set forth in the Registration Statement when available.

     

    Youlife, Pubco and their directors and executive officers may also be deemed to be participants in the solicitation of proxies from the shareholders of Distoken in connection with the Business Combination. A list of the names of such directors and executive officers and information regarding their interests in the Business Combination are included in the Registration Statement.

     

    Non-Solicitation

     

    This Current Report on Form 8-K does not constitute, and should not be construed to be, a proxy statement or the solicitation of a proxy, solicitation of any vote or approval, consent or authorization with respect to any securities or in respect of the proposed Business Combination described herein and shall not constitute an offer to sell or a solicitation of an offer to buy any securities nor shall there be any sale of securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act, or an exemption therefrom.

     

    Forward-Looking Statements

     

    This Current Report on Form 8-K contains certain statements that may be considered forward-looking statements within the meaning of the federal securities laws. Forward-looking statements include, without limitation, statements about future events or Distoken’s, Youlife’s or Pubco’s future financial or operating performance. For example, statements regarding Youlife’s anticipated growth and the anticipated growth in demand for Youlife’s products, services and solutions, the anticipated size of Youlife’s addressable market and other metrics, statements regarding the benefits of the Business Combination, and the anticipated timing of the completion of the Business Combination are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “might,” “plan,” “possible,” “project,” “strive,” “budget,” “forecast,” “expect,” “intend,” “will,” “estimate,” “anticipate,” “believe,” “predict,” “potential” or “continue,” or the negatives of these terms or variations of them or similar terminology.

     

    These forward-looking statements regarding future events and the future results of Distoken, Youlife and Pubco are based on current expectations, estimates, forecasts, and projections about the industry in which Youlife operates, as well as the beliefs and assumptions of Distoken’s management and Youlife’s management. These forward-looking statements are only predictions and are subject to known and unknown risks, uncertainties, assumptions and other factors beyond Distoken’s, Youlife’s or Pubco’s control that are difficult to predict because they relate to events and depend on circumstances that will occur in the future. They are neither statements of historical fact nor promises or guarantees of future performance. Therefore, Youlife’s and Pubco’s actual results may differ materially and adversely from those expressed or implied in any forward-looking statements and Distoken, Youlife and Pubco therefore caution against relying on any of these forward-looking statements.

     

     
     

     

    These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by Distoken and its management, Youlife and its management, and Pubco and its management, as the case may be, are inherently uncertain and are inherently subject to risks, variability and contingencies, many of which are beyond Distoken’s, Youlife’s or Pubco’s control. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (i) the occurrence of any event, change or other circumstances that could give rise to the termination of the Business Combination Agreement and any subsequent definitive agreements with respect to the Business Combination; (ii) the outcome of any legal proceedings that may be instituted against Distoken, Youlife, Pubco or others following the announcement of the Business Combination and any definitive agreements with respect thereto; (iii) the inability to complete the Business Combination due to the failure to obtain consents and approvals of the shareholders of Distoken, to obtain financing to complete the Business Combination or to satisfy other conditions to closing, or delays in obtaining, adverse conditions contained in, or the inability to obtain necessary regulatory approvals required to complete the transactions contemplated by the Business Combination Agreement; (iv) changes to the proposed structure of the Business Combination that may be required or appropriate as a result of applicable laws or regulations or as a condition to obtaining regulatory approval of the Business Combination; (v) projections, estimates and forecasts of revenue and other financial and performance metrics, projections of market opportunity and expectations, and the estimated implied enterprise value of Pubco; (vi) Youlife’s and Pubco’s ability to scale and grow its business, and the advantages and expected growth of Pubco; (vii) Pubco’s ability to source and retain talent, the cash position of Pubco following closing of the Business Combination; (viii) the ability to meet stock exchange listing standards in connection with, and following, the consummation of the Business Combination; (ix) the risk that the Business Combination disrupts current plans and operations of Youlife as a result of the announcement and consummation of the Business Combination; (x) the ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, competition, the ability of Pubco or Youlife to grow and manage growth profitably, maintain key relationships and retain its management and key employees; (xi) costs related to the Business Combination; (xii) changes in applicable laws, regulations, political and economic developments; (xiii) the possibility that Youlife or Pubco may be adversely affected by other economic, business and/or competitive factors; (xiv) Youlife’s estimates of expenses and profitability; (xv) the failure to realize estimated shareholder redemptions, purchase price and other adjustments; and (xvi) other risks and uncertainties set forth in the filings by Distoken or Pubco with the SEC. There may be additional risks that neither Distoken nor Youlife presently know or that Distoken and Youlife currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. Any forward-looking statements made by or on behalf of Distoken, Youlife or Pubco speak only as of the date they are made. None of Distoken, Youlife or Pubco undertakes any obligation to update any forward-looking statements to reflect any changes in their respective expectations with regard thereto or any changes in events, conditions or circumstances on which any such statement is based.

     

    Item 9.01. Financial Statements and Exhibits.

     

    (d) Exhibits.

     

    The following exhibits are being filed herewith:

     

    Exhibit No.   Description
         
    10.1   Form of First Amendment to Subscription Agreement by and among Distoken, Pubco and the Subscriber party thereto.
         
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

     

     
     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      Distoken Acquisition Corporation
         
    Date: May 30, 2025 By: /s/ Jian Zhang
      Name: Jian Zhang
      Title: Chief Executive Officer

     

     

     

     

    Exhibit 10.1

     

    FORM OF FIRST AMENDMENT

     

    TO

     

    SUBSCRIPTION AGREEMENT

     

    This First Amendment (“First Amendment”) to the Subscription Agreement (as defined below) is made and entered into as of May            , 2025 by and among Distoken Acquisition Corporation, an exempted company incorporated under the laws of the Cayman Islands (“SPAC”), Youlife Group Inc., an exempted company newly formed under the laws of the Cayman Islands (the “Issuer”) and the undersigned subscriber (the “Investor”), in connection with the Business Combination Agreement, dated as of May 17, 2024, as amended on November 13, 2024 and January 17, 2025 (as it may be further amended, supplemented or otherwise modified from time to time, the “Transaction Agreement”), by and among SPAC, the Issuer, Youlife International Holdings Inc., an exempted company incorporated under the laws of the Cayman Islands (the “Company”) and the other parties thereto. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Subscription Agreement (as defined below).

     

    RECITALS:

     

    WHEREAS, the SPAC, the Issuer and the Investor have entered into that certain Subscription Agreement, dated as of April       , 2025 (the “Original Agreement,” and as amended, including by this First Amendment, the “Subscription Agreement”); and

     

    WHEREAS, Section 12(g) of the Original Agreement provides that the Original Agreement may not be modified, waived or terminated except by an instrument in writing, signed by each of the parties thereto, provided, however, that no modification or waiver by the Issuer of the provisions of the Original Agreement prior to the Closing shall be effective without the prior written consent of the Company (other than modifications or waivers that are solely ministerial in nature or otherwise immaterial and do not affect any economic or any other material term of this Subscription Agreement); and

     

    WHEREAS, the Parties now desire to amend the Original Agreement to extend the long stop date.

     

     
     

     

    NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and in accordance with the terms of the Subscription Agreement, the parties hereto, intending to be legally bound, do hereby acknowledge and agree as follows:

     

    1. Amendments to Subscription Agreement.

     

    (a) Section 10 of the Original Agreement is hereby amended by replacing it in its entirety with the following:

     

    “(a) This Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of the parties hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earliest to occur of (i) such date and time as the Transaction Agreement is terminated in accordance with its terms without being consummated, and (ii) the mutual written agreement of each of the parties hereto and the Company to terminate this Subscription Agreement, and (b) this Subscription Agreement may be terminated by any party by giving written notice to the other parties hereto, in which case this Subscription Agreement shall be void and of no further force and effect, and all rights and obligations of the parties hereunder shall terminate without any further liability on the part of any party in respect thereof, if the Closing has not occurred by June 30, 2025 other than as a result of a breach of the Investor’s obligations hereunder; provided that nothing herein will relieve any party from liability for any willful breach hereof prior to the time of termination, and each party will be entitled to any remedies at law or in equity to recover losses, liabilities or damages arising from any such willful breach. The Issuer shall notify the Investor in writing of the termination of the Transaction Agreement promptly after the termination of such agreement. Upon the termination of this Subscription Agreement in accordance with clause (a) or (b) above , this Subscription Agreement shall be void and of no further effect and any monies paid by the Investor to the Issuer in connection herewith shall promptly (and in any event within two (2) business days) following the termination of this Subscription Agreement be returned to the Investor. “

     

    2. Miscellaneous. Except as expressly provided in this First Amendment, all of the terms and provisions in the Original Agreement are and shall remain unchanged and in full force and effect, on the terms and subject to the conditions set forth therein. This First Amendment does not constitute, directly or by implication, an amendment or waiver of any provision of the Original Agreement, or any other right, remedy, power or privilege of any party, except as expressly set forth herein. Any reference to the Subscription Agreement in the Subscription Agreement or any other agreement, document, instrument or certificate entered into or issued in connection therewith shall hereinafter mean the Original Agreement, as amended by this First Amendment (or as the Subscription Agreement may be further amended or modified after the date hereof in accordance with the terms thereof). The Original Agreement, as amended by this First Amendment, and the documents or instruments attached hereto or thereto or referenced herein or therein, constitutes the entire agreement between the parties with respect to the subject matter of the Subscription Agreement, and supersedes all prior agreements and understandings, both oral and written, between the parties with respect to its subject matter. If any provision of the Original Agreement is materially different from or inconsistent with any provision of this First Amendment, the provision of this First Amendment shall control, and the provision of the Original Agreement shall, to the extent of such difference or inconsistency, be disregarded. Section 12 of the Original Agreement are hereby incorporated herein by reference as if fully set forth herein, and such provisions apply to this First Amendment as if all references to the “Subscription Agreement” contained therein were instead references to this First Amendment.

     

    [Remainder of Page Intentionally Left Blank; Signature Pages Follow]

     

     
     

     

    IN WITNESS WHEREOF, each party hereto has caused this First Amendment to be signed and delivered as of the date first written above.

     

      The Issuer: Youlife Group Inc.
         
      By:  
      Name:  
      Title:  

     

     
     

     

    IN WITNESS WHEREOF, each party hereto has caused this First Amendment to be signed and delivered as of the date first written above.

     

      SPAC: Distoken Acquisition Corporation
         
      By:          
      Name:  
      Title:  

     

     
     

     

    IN WITNESS WHEREOF, each party hereto has caused this First Amendment to be signed and delivered as of the date first written above.

     

      The Investor:
         
      By:     
      Name:  
      Title:  

     

     

    Get the next $DIST alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DIST

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DIST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO and Chairman Zhang Jian disposed of 2,270,000 units of Ordinary Shares (SEC Form 4)

    4 - Distoken Acquisition Corp (0001818605) (Issuer)

    7/11/25 4:00:18 PM ET
    $DIST
    Blank Checks
    Finance

    $DIST
    SEC Filings

    View All

    SEC Form 15-12G filed by Distoken Acquisition Corporation

    15-12G - Distoken Acquisition Corp (0001818605) (Filer)

    7/22/25 7:25:51 AM ET
    $DIST
    Blank Checks
    Finance

    Distoken Acquisition Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - Distoken Acquisition Corp (0001818605) (Filer)

    7/15/25 5:22:59 PM ET
    $DIST
    Blank Checks
    Finance

    SEC Form 25-NSE filed by Distoken Acquisition Corporation

    25-NSE - Distoken Acquisition Corp (0001818605) (Subject)

    7/9/25 4:20:14 PM ET
    $DIST
    Blank Checks
    Finance

    $DIST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Distoken Acquisition Corporation Receives Expected Notice from Nasdaq Regarding Delayed Quarterly Filing

    KUNMING, China, June 5, 2024 /PRNewswire/ -- Distoken Acquisition Corporation (NASDAQ:DIST) (the "Company") announced today that it received a notice ("Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule") because the Company failed to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 (the "Form 10-Q") with the Securities and Exchange Commission ("SEC"). The Notice has no immediate effect on the listing or trading of the Company's securities on the Nasdaq Global Market. The Company is working diligently to finalize the financial s

    6/5/24 8:00:00 AM ET
    $DIST
    Blank Checks
    Finance

    Youlife International and Distoken Acquisition Corporation Announce Definitive Business Combination Agreement

    Youlife International to Go Public in the U.S. Through such Business Combination, Opening up a New Horizon for Long-Term Development SHANGHAI, May 20, 2024 /PRNewswire/ -- Youlife International Holdings Inc., a leading blue-collar lifetime service platform in China ("Youlife"), and Distoken Acquisition Corporation (NASDAQ:DIST), a publicly traded special purpose acquisition company ("Distoken"), announced today that they have entered into a definitive business combination agreement (the "Business Combination Agreement") for a proposed business combination (the "Business Combination"). Pursuant to the Business Combination Agreement, each of Youlife and Distoken will merge with newly-formed su

    5/20/24 9:28:00 AM ET
    $DIST
    Blank Checks
    Finance

    $DIST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Distoken Acquisition Corporation

    SC 13G/A - Distoken Acquisition Corp (0001818605) (Subject)

    12/6/24 4:17:44 PM ET
    $DIST
    Blank Checks
    Finance

    Amendment: SEC Form SC 13G/A filed by Distoken Acquisition Corporation

    SC 13G/A - Distoken Acquisition Corp (0001818605) (Subject)

    11/14/24 6:11:18 PM ET
    $DIST
    Blank Checks
    Finance

    SEC Form SC 13G filed by Distoken Acquisition Corporation

    SC 13G - Distoken Acquisition Corp (0001818605) (Subject)

    11/14/24 2:49:26 PM ET
    $DIST
    Blank Checks
    Finance